Cost-effectiveness analysis of iStent Inject® implantation during cataract surgery compared to cataract surgery alone for mild to moderate open-angle glaucoma patients in Spain

References

• Giangiacomo A, Coleman AL. The Epidemiology of Glaucoma. In: Berlin, Heidelberg, Glaucoma. Berlin Heidelberg: Springer; 2009. 13–21. DOI: 10.1007/978-3-540-69475-5_2.
   Google Scholar
• Antón A, Andrada MT, Mujica V, et al. Prevalence of primary open-angle glaucoma in a Spanish population: the Segovia study. J Glaucoma. 2004;13(5):371–376. 00061198-200410000-00005 [pii].
   PubMed Web of Science ®Google Scholar
• Weinreb RN, Aung T, Medeiros FA. The Pathophysiology and Treatment of Glaucoma. JAMA 1901;311:2014.
   Google Scholar
• Grupo de trabajo de la Guía de práctica clínica sobre el glaucoma de ángulo abierto: guía de Práctica Clínica sobre Glaucoma de Ángulo Abierto. Minist. Sanidad, Serv. Soc. e Igualdad. Agència Qual. i Avaluació Sanitàries Catalunya y el Cent. Cochrane Iberoam. Guías de P, (2017)
   Google Scholar
• Traverso CE. Direct costs of glaucoma and severity of the disease: a multinational long term study of resource utilisation in Europe. Br J Ophthalmol. 2005;89(10):1245–1249.
   PubMed Web of Science ®Google Scholar
• Ernst, Young SL. Retinaplus+. Informe sobre la ceguera en España. 2012. [cited 2018 Jul]. Available from: http://www.fundacionretinaplus.es/images/documentos/Informe_Ceguera.pdf.
   Google Scholar
• European Glaucoma Society Terminology and Guidelines for Glaucoma. 4th Edition - Chapter 3: treatment principles and optionsSupported by the EGS Foundation. Br J Ophthalmol. 2017;101(6):130–195.
   PubMedGoogle Scholar
• Prum BE, Rosenberg LF, Gedde SJ, et al. Primary Open-Angle Glaucoma Preferred Practice Pattern® Guidelines. Ophthalmology. 2016;123(1): P41–P111.
   Google Scholar
• Coleman AL, Richter G. Minimally invasive glaucoma surgery: current status and future prospects. Clin Ophthalmol. 2016;10:189.
   PubMed Web of Science ®Google Scholar
• Prevalence of glaucoma in cataract surgery population. 2017. [cited 2021 Mar 16]. Available from:http://www.eyeworld.org/best-ascrs-glaucoma
   Google Scholar
• iStent inject® Directions for Use. [cited 2019 Jan]. Available from: https://www.glaukos.com/wp-content/uploads/2017/09/45-0176-Rev-1-Artwork-IFU-G2-M-IS-Commerical-US-1.pdf.
   Google Scholar
• Fea AM, Belda Sanchis JI, Rękas, et al. Prospective unmasked randomized evaluation of the iStent inject versus two ocular hypotensive agents in patients with primary open-angle glaucoma. Clin Ophthalmol. 2014;8:875–882.
   PubMedGoogle Scholar
• Clement CI, Howes F, Ioannidis AS, et al. One-year outcomes following implantation of second-generation trabecular micro-bypass stents in conjunction with cataract surgery for various types of glaucoma or ocular hypertension: multicenter, multi-surgeon study. Clin Ophthalmol. 2019;13:491–499.
   PubMed Web of Science ®Google Scholar
• Hengerer FH, Auffarth GU, Riffel C, et al. Prospective, Non-randomized, 36-Month Study of Second-Generation Trabecular Micro-Bypass Stents with Phacoemulsification in Eyes with Various Types of Glaucoma. Ophthalmol Ther. 2018;7(2):405–415.
   PubMed Web of Science ®Google Scholar
• Voskanyan L, García-Feijoó J, Belda JI, et al. Prospective, unmasked evaluation of the iStent® Inject system for open-angle glaucoma: synergy trial. Adv Ther. 2014;31(2):189–201.
   PubMed Web of Science ®Google Scholar
• Gillmann K, Mansouri K, Ambresin A, et al. A Prospective Analysis of iStent Inject Microstent Implantation: surgical Outcomes, Endothelial Cell Density, and Device Position at 12 Months. J Glaucoma. 2020 Aug;29(8):639–647. PMID: 32433094.
   PubMed Web of Science ®Google Scholar
• Katz LJ, Erb C, Carceller Guillamet A, et al. Long-term titrated IOP control with one, two, or three trabecular micro-bypass stents in open-angle glaucoma subjects on topical hypotensive medication: 42-month outcomes. Clin Ophthalmol. 2018;12:255–262.
   PubMed Web of Science ®Google Scholar
• Samuelson TW, Sarkisian SR, Lubeck DM, et al. Prospective, Randomized, Controlled Pivotal Trial of an Ab Interno Implanted Trabecular Micro-Bypass in Primary Open-Angle Glaucoma and Cataract. Ophthalmology. 2019;126(6):811–821.
   PubMed Web of Science ®Google Scholar
• Malvankar-Mehta MS, Iordanous Y, Chen YN, et al. iStent with Phacoemulsification versus Phacoemulsification Alone for Patients with Glaucoma and Cataract: a Meta-Analysis. PLoS One. 2015;10(7):e0131770.
   PubMed Web of Science ®Google Scholar
• Ling JD, Bell NP. Role of Cataract Surgery in the Management of Glaucoma. Int Ophthalmol Clin. 2018;58(3):87–100.
   PubMedGoogle Scholar
• Kung JS, Choi DY, Cheema AS, et al. Cataract surgery in the glaucoma patient. Middle East Afr J Ophthalmol. 2015;22(1):10–17.
   PubMed Web of Science ®Google Scholar
• Husereau D, Drummond M, Petrou S, et al. Consolidated Health Economic Evaluation Reporting Standards (CHEERS) statement. BMC Med. 2013;11(1). DOI:10.1186/1741-7015-11-80.
   PubMed Web of Science ®Google Scholar
• Glaucoma Grading Scale (Hodapp-Parrish-Anderson) - OphthaClass [Internet]. [cited 2018 Jun]. Available from: http://ophthaclassification.altervista.org/glaucoma-grading-scale-hodapp-parrish-anderson/.
   Google Scholar
• Musch DC, Gillespie BW, Palmberg PF, et al. Visual field improvement in the collaborative initial glaucoma treatment study. Am J Ophthalmol. 2014;158(1):96.
   PubMed Web of Science ®Google Scholar
• Abdel Gfiany AF, Botros SM, El-Raggal TM. Central retinal artery resistive index and optical coherence tomography in assessment of glaucoma progression. Int J Ophthalmol. 2015;8(2):305–309.
   PubMed Web of Science ®Google Scholar
• Heijl A, Leske MC, Bengtsson B, et al. Reduction of intraocular pressure and glaucoma progression. Arch Ophthalmol. 2002;120(10):1268–1279.
   PubMed Web of Science ®Google Scholar
• Instituto Nacional de Estadística (INE). Tablas de Mortalidad de la Poblacion Española. Serie 1991–2016. Tablas de mortalidad de la población de España por año, sexo, edad y funciones. [cited 2018 Jul]. Available from: https://www.ine.es/jaxiT3/Tabla.htm?t=27155.
   Google Scholar
• López-Bastida J, Oliva J, Antoñanzas, et al. Spanish recommendations on economic evaluation of health technologies. Eur J Heal. Econ. 2010;11(5):513–520.
   PubMed Web of Science ®Google Scholar
• Puig-Junoy J, Oliva-Moreno J, Trapero-Bertrán M, et al. Guía y recomendaciones para la realización y presentación de evaluaciones económicas y análisis de impacto presupuestario de medicamentos en el ámbito del CatSalut. General. Catalunya. Dep. Salut. Serv. Català la Salut Barcelona. 2014;2014:9–11.
   Google Scholar
• Fernández-Barrientos Y, García-Feijoo J, Martínez-de-la-Casa, et al. Fluorophotometric study of the effect of the glaukos trabecular microbypass stent on aqueous humor dynamics. Investig Ophthalmol Vis Sci. 2010;51:3327–3332.
   PubMed Web of Science ®Google Scholar
• Arriola-Villalobos P, Martinez-de-la-casa JM, Diaz-Valle D, et al. Glaukos iStent inject® Trabecular Micro-Bypass Implantation Associated with Cataract Surgery in Patients with Coexisting Cataract and Open-Angle Glaucoma or Ocular Hypertension: a Long-Term Study. J Ophthalmol. 2016;1–7:2016.
   Google Scholar
• Fong D, Batech M. Lower levels of adherence to topical glaucoma medications are associated with increased risk of visual field progression. In: Investigative Ophthalmology and Visual Science. Vol. 58. 2017. p. 8.
   Google Scholar
• Russo V, Barone A, Cosma A. Selective laser trabeculoplasty versus argon laser trabeculoplasty in patients with open-angle glaucoma. Eur. J. ophthanmology. 2009;19(3):429–434.
   PubMed Web of Science ®Google Scholar
• National Collaborating Centre for Acute Care: glaucoma. Diagnosis and management of chronic open angle glaucoma and ocular hypertension. Methods, evidence & guidance.. Available at: https://www.ncbi.nlm.nih.gov/pubmed/21938863. (2009). Accesed July, 2018. London: National institute for health and clinical excellence; .
   Google Scholar
• Sihota R, Angmo D, Ramaswamy D, et al. Simplifying target intraocular pressure for different stages of primary open-angle glaucoma and primary angle-closure glaucoma. Indian J Ophthalmol. 2018;66(4):495–505.
   PubMed Web of Science ®Google Scholar
• van Gestel A, Webers CAB, Beckers HJM, et al. The relationship between visual field loss in glaucoma and health-related quality-of-life. Eye 2010;24(12):1759–1769.
   PubMed Web of Science ®Google Scholar
• Hommer A, Wickstrøm J, Friis, et al. A cost-effectiveness analysis of fixed-combination therapies in patients with open-angle glaucoma: a European perspective. Curr. Med. Res. Opin. 2008;24(4):1057–1063.
   PubMed Web of Science ®Google Scholar
• Van Gestel A, Schouten JSAG, Beckers HJM, et al. The long term effectiveness and cost-effectiveness of initiating treatment for ocular hypertension. Acta Ophthalmol. 2014;92(6):513–523.
   PubMed Web of Science ®Google Scholar
• Van Gestel A, Webers CA, Severens, et al. The long-term outcomes of four alternative treatment strategies for primary open-angle glaucoma. Acta Ophthalmol. 2012;90(1):20–31.
   PubMed Web of Science ®Google Scholar
• Oliva Moreno J. Los costes de los cuidados informales en España. Madrid. Inst. Estud. Fisc. Secr. Gen. Presup. y Gastos. Presupuest. 2009;163–181.
   Google Scholar
• Oliva J, Brosa M, Espín J, et al. Cuestiones controvertidas en evaluación económica (I): perspectiva y costes de intervenciones sanitarias. 2015;5–14.
   Google Scholar
• Gisbert RY, Brosa M. Base de datos de costes sanitarios y ratios coste-efectividad españoles: eSalud [Internet]. Barcelona: Oblikue Consulting, S.L; 2018. Available from: http://www.oblikue.com/bddcostes/.
   Google Scholar
• Consejo General de Colegios Oficiales de Farmacéuticos.: bot Plus Web
   Google Scholar
• IQVIA: datos de prescripción de los medicamentos oftámicos para el tratamiento del glaucoma., (2018)
   Google Scholar
• Instituto nacional de estadística (INE): Series por sectores de actividad y componentes del coste (31305). Coste total por trabajador (T4–2018)
   Google Scholar
• Lafuma A, Brézin A, Lopatriello S, et al. Evaluation of Non-Medical Costs Associated with Visual Impairment in Four European Countries. PharmacoEconomics. 2006;24(2):193–205.
   PubMed Web of Science ®Google Scholar
• Belhassen M, Laforest L, Licaj I, et al. Étude Observationnelle Sur L’Adhésion Précoce Aux Traitements Hypotonisants Anti-Glaucomateux. Therapie. 2016;71(5):491–499.
   PubMed Web of Science ®Google Scholar
• Ortega A, Marín R, Fraga MD, et al. Guía de evaluación económica e impacto presupuestario en los informes de evaluación de medicamentos. Guía Práctica. 2016.
   Google Scholar
• Ordóñez JE, Ordóñez A, Osorio UM. Cost-effectiveness analysis of iStent trabecular micro-bypass stent for patients with open-angle glaucoma in Colombia. Curr. Med. Res. Opin. 2019;35(2):329–340.
   PubMed Web of Science ®Google Scholar
• Patel V, Ahmed I, Podbielski D, et al. Cost-effectiveness analysis of standalone trabecular micro-bypass stents in patients with mild-to-moderate open-angle glaucoma in Canada. J. Med. Econ. 2019;22(4):390–401.
   PubMed Web of Science ®Google Scholar